Response to Julia Tapia
Hello Julia, I agree with you in your discussion that the primary form of medication for type 1 diabetes is injected insulin, which is typically injected subcutaneously into the fatty tissue of the abdomen or upper arms. Beck et al. (2017), asserted that whereas insulin may be good for the treatment of type 1 diabetes, it may cause side effects to the patient, which include severe allergic reactions that result in rashes all over the body, heart failure as a result of reduced breathing. Education to type 1 diabetic patients may include the practice of healthy eating habits like reducing consumption of highly-sugary foods, and enlightenment of the necessary skills to handle stress. Oral medications for type 2 diabetes may result in kidney dysfunctions.
Reference
Beck, R. W., Riddlesworth, T., Ruedy, K., Ahmann, A., Bergenstal, R., Haller, S., … & Toschi, E. (2017). Effect of continuous glucose monitoring on glycemic control in adults with type 1 diabetes using insulin injections: the DIAMOND randomized clinical trial. Jama, 317(4), 371-378.
Response to Yesenia Esquivel
Hello Yesenia, I support you in your discussion. Oral medication is only able to help in the case of type 2 diabetes because the pancreas is actively producing insulin, while patients with type 2 diabetes can benefit by taking both oral medication and insulin. Another oral medication for type 2 diabetes is alpha-glucosidase inhibitors like Glyset and precise. These medications work by breaking down carbohydrates and thus reducing sugar levels in the body. However, alpha-glucosidase inhibitors may have side effects on the patient, which includes increased gas in the body, diarrhea, and issues of bloating. For patients who have individual testing in their residential areas, they may be educated on how to use the instruments like the blood glucose meters and insulin pumps (Vettoretti, Facchinetti, Sparacino & Cobelli, 2017).
Reference
Vettoretti, M., Facchinetti, A., Sparacino, G., & Cobelli, C. (2017). Type-1 diabetes patient decision simulator for in silico testing safety and effectiveness of insulin treatments. IEEE Transactions on Biomedical Engineering, 65(6), 1281-1290.